Trial Profile
Scandinavian study investigating the effects of everolimus + reduced-dose calcineurin inhibitors versus standard dose calcineurin inhibitors on cardiac allograft vasculopathy.
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 18 Apr 2011
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Azathioprine; Calcineurin inhibitors; Mycophenolate mofetil
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.